| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 484 |
| 1 | DABIGATRAN ETEXILATE | 338 |
| 2 | DABIGATRAN ETEXILATE MESYLATE | 312 |
| 3 | FUROSEMIDE | 137 |
| 4 | BISOPROLOL FUMARATE | 106 |
| 5 | WARFARIN | 106 |
| 6 | ASPIRIN | 99 |
| 7 | ASPIRIN 325 MG | 98 |
| 8 | ASPIRIN 81 MG | 98 |
| 9 | METOPROLOL TARTRATE | 96 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SALINE LAXATIVE | 1 | 0.1250 |
| 1 | URIC ACID | 1 | 0.0435 |
| 2 | KAOLIN | 1 | 0.0182 |
| 3 | DEXTRAN 40 | 1 | 0.0139 |
| 4 | CHLORHEXIDINE GLUCONATE ORAL RINSE | 1 | 0.0119 |
| 5 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 6 | DIAZOXIDE | 5 | 0.0068 |
| 7 | CALASPARGASE PEGOL | 4 | 0.0050 |
| 8 | ANTI-INHIBITOR COAGULANT COMPLEX | 5 | 0.0045 |
| 9 | DABIGATRAN ETEXILATE | 338 | 0.0044 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 567 |
| 1 | Loop Diuretic [EPC] | 156 |
| 2 | Corticosteroid [EPC] | 155 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 142 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 102 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 85 |
| 6 | Aldosterone Antagonist [EPC] | 84 |
| 7 | Proton Pump Inhibitor [EPC] | 76 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 60 |
| 9 | Cardiac Glycoside [EPC] | 59 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 567 | 0.0021 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 2 | Anti-coagulant [EPC] | 6 | 0.0016 |
| 3 | Asparagine-specific Enzyme [EPC] | 18 | 0.0013 |
| 4 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 5 | Antifibrinolytic Agent [EPC] | 9 | 0.0009 |
| 6 | Actinomycin [EPC] | 2 | 0.0009 |
| 7 | Cardiac Glycoside [EPC] | 59 | 0.0008 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 9 | Leptin Analog [EPC] | 1 | 0.0008 |